BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18798267)

  • 21. An antimetastatic role for decorin in breast cancer.
    Goldoni S; Seidler DG; Heath J; Fassan M; Baffa R; Thakur ML; Owens RT; McQuillan DJ; Iozzo RV
    Am J Pathol; 2008 Sep; 173(3):844-55. PubMed ID: 18688028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological functions of decorin in cancer.
    Bi XL; Yang W
    Chin J Cancer; 2013 May; 32(5):266-9. PubMed ID: 23601240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans.
    Iozzo RV; Schaefer L
    FEBS J; 2010 Oct; 277(19):3864-75. PubMed ID: 20840584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrillogenesis of collagen types I, II, and III with small leucine-rich proteoglycans decorin and biglycan.
    Douglas T; Heinemann S; Bierbaum S; Scharnweber D; Worch H
    Biomacromolecules; 2006 Aug; 7(8):2388-93. PubMed ID: 16903686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells.
    Zafiropoulos A; Nikitovic D; Katonis P; Tsatsakis A; Karamanos NK; Tzanakakis GN
    Mol Cancer Res; 2008 May; 6(5):785-94. PubMed ID: 18505923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel 110-kDa receptor protein is involved in endocytic uptake of decorin by human skin fibroblasts.
    Sofeu Feugaing DD; Kresse H; Greb RR; Götte M
    ScientificWorldJournal; 2006 Jan; 6():35-52. PubMed ID: 16432627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle.
    Waehre A; Vistnes M; Sjaastad I; Nygård S; Husberg C; Lunde IG; Aukrust P; Yndestad A; Vinge LE; Behmen D; Neukamm C; Brun H; Thaulow E; Christensen G
    J Appl Physiol (1985); 2012 Apr; 112(8):1372-82. PubMed ID: 22345433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.
    Chen XD; Fisher LW; Robey PG; Young MF
    FASEB J; 2004 Jun; 18(9):948-58. PubMed ID: 15173106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural change in decorin with skin aging.
    Nomura Y
    Connect Tissue Res; 2006; 47(5):249-55. PubMed ID: 17118746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decorin prevents metastatic spreading of breast cancer.
    Reed CC; Waterhouse A; Kirby S; Kay P; Owens RT; McQuillan DJ; Iozzo RV
    Oncogene; 2005 Feb; 24(6):1104-10. PubMed ID: 15690056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.
    Iozzo RV; Sanderson RD
    J Cell Mol Med; 2011 May; 15(5):1013-31. PubMed ID: 21155971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells.
    Patel S; Santra M; McQuillan DJ; Iozzo RV; Thomas AP
    J Biol Chem; 1998 Feb; 273(6):3121-4. PubMed ID: 9452417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expressions of small leucine-rich repeat proteoglycans and fibulin-5 are decreased in pelvic organ prolapse.
    Söderberg MW; Byström B; Kalamajski S; Malmström A; Ekman-Ordeberg G
    Mol Hum Reprod; 2009 Apr; 15(4):251-7. PubMed ID: 19251763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy.
    Choi IK; Lee YS; Yoo JY; Yoon AR; Kim H; Kim DS; Seidler DG; Kim JH; Yun CO
    Gene Ther; 2010 Feb; 17(2):190-201. PubMed ID: 19907500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen.
    Schönherr E; Broszat M; Brandan E; Bruckner P; Kresse H
    Arch Biochem Biophys; 1998 Jul; 355(2):241-8. PubMed ID: 9675033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small proteoglycans.
    Kresse H; Hausser H; Schönherr E
    Experientia; 1993 May; 49(5):403-16. PubMed ID: 8500596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteoglycans: from structural compounds to signaling molecules.
    Schaefer L; Schaefer RM
    Cell Tissue Res; 2010 Jan; 339(1):237-46. PubMed ID: 19513755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decorin suppresses bone metastasis in a breast cancer cell line.
    Araki K; Wakabayashi H; Shintani K; Morikawa J; Matsumine A; Kusuzaki K; Sudo A; Uchida A
    Oncology; 2009; 77(2):92-9. PubMed ID: 19590249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells.
    Li X; McFarland DC; Velleman SG
    Domest Anim Endocrinol; 2008 Oct; 35(3):263-73. PubMed ID: 18650056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decorin in the Tumor Microenvironment.
    Baghy K; Reszegi A; Tátrai P; Kovalszky I
    Adv Exp Med Biol; 2020; 1272():17-38. PubMed ID: 32845500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.